Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 69


Beneficial and adverse effects of antipsychotic medication on cognitive flexibility are related to COMT genotype in first episode psychosis.

Nelson CLM, Amsbaugh HM, Reilly JL, Rosen C, Marvin RW, Ragozzino ME, Bishop JR, Sweeney JA, Hill SK.

Schizophr Res. 2018 Jun 22. pii: S0920-9964(18)30363-3. doi: 10.1016/j.schres.2018.06.029. [Epub ahead of print]


Comparing Existing Resources to Represent Dietary Supplements.

Rizvi RF, Adam TJ, Lindemann EA, Vasilakes J, Pakhomov SV, Bishop JR, Melton GB, Zhang R.

AMIA Jt Summits Transl Sci Proc. 2018 May 18;2017:207-216. eCollection 2018.


Cognitive Burden of Common Non-antiretroviral Medications in HIV-Infected Women.

Rubin LH, Radtke KK, Eum S, Tamraz B, Kumanan KN, Springer G, Maki PM, Anastos K, Merenstein D, Karim R, Weber KM, Gustafson D, Greenblatt RM, Bishop JR.

J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):83-91. doi: 10.1097/QAI.0000000000001755.


Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls.

Shafee R, Nanda P, Padmanabhan JL, Tandon N, Alliey-Rodriguez N, Kalapurakkel S, Weiner DJ, Gur RE, Keefe RSE, Hill SK, Bishop JR, Clementz BA, Tamminga CA, Gershon ES, Pearlson GD, Keshavan MS, Sweeney JA, McCarroll SA, Robinson EB.

Transl Psychiatry. 2018 Apr 12;8(1):78. doi: 10.1038/s41398-018-0124-8.



Bishop JR.

Handb Clin Neurol. 2018;147:59-73. doi: 10.1016/B978-0-444-63233-3.00006-3. Review.


Genetic analysis of deep phenotyping projects in common disorders.

Gershon ES, Pearlson G, Keshavan MS, Tamminga C, Clementz B, Buckley PF, Alliey-Rodriguez N, Liu C, Sweeney JA, Keedy S, Meda SA, Tandon N, Shafee R, Bishop JR, Ivleva EI.

Schizophr Res. 2018 May;195:51-57. doi: 10.1016/j.schres.2017.09.031. Epub 2017 Oct 20. Review.


Precision Pharmacotherapy Enables Precision Medicine.

Bishop JR, Ellingrod VL.

Pharmacotherapy. 2017 Sep;37(9):985-987. doi: 10.1002/phar.1998. Epub 2017 Aug 23. No abstract available.


Pharmacogenetic evaluation to assess breakthrough psychosis with aripiprazole long-acting injection: a case report.

Eum S, Schneiderhan ME, Brown JT, Lee AM, Bishop JR.

BMC Psychiatry. 2017 Jul 3;17(1):238. doi: 10.1186/s12888-017-1396-x.


Collaborative Counseling Considerations for Pharmacogenomic Tests.

Zierhut HA, Campbell CA, Mitchell AG, Lemke AA, Mills R, Bishop JR.

Pharmacotherapy. 2017 Sep;37(9):990-999. doi: 10.1002/phar.1980. Epub 2017 Aug 7. Review.


Serum clomipramine and desmethylclomipramine levels in a CYP2C19 and CYP2D6 intermediate metabolizer.

Brown JT, Schneiderhan M, Eum S, Bishop JR.

Pharmacogenomics. 2017 May;18(7):601-605. doi: 10.2217/pgs-2017-0015. Epub 2017 May 4. Review.


Cognitive burden of anticholinergic medications in psychotic disorders.

Eum S, Hill SK, Rubin LH, Carnahan RM, Reilly JL, Ivleva EI, Keedy SK, Tamminga CA, Pearlson GD, Clementz BA, Gershon ES, Keshavan MS, Keefe RSE, Sweeney JA, Bishop JR.

Schizophr Res. 2017 Dec;190:129-135. doi: 10.1016/j.schres.2017.03.034. Epub 2017 Apr 6.


Pharmacogenomics of autism spectrum disorder.

Brown JT, Eum S, Cook EH, Bishop JR.

Pharmacogenomics. 2017 Mar;18(4):403-414. doi: 10.2217/pgs-2016-0167. Epub 2017 Feb 22. Review.


Sex differences in associations of arginine vasopressin and oxytocin with resting-state functional brain connectivity.

Rubin LH, Yao L, Keedy SK, Reilly JL, Bishop JR, Carter CS, Pournajafi-Nazarloo H, Drogos LL, Tamminga CA, Pearlson GD, Keshavan MS, Clementz BA, Hill SK, Liao W, Ji GJ, Lui S, Sweeney JA.

J Neurosci Res. 2017 Jan 2;95(1-2):576-586. doi: 10.1002/jnr.23820.


Pharmacogenetic tests for antipsychotic medications: clinical implications and considerations.

Eum S, Lee AM, Bishop JR.

Dialogues Clin Neurosci. 2016 Sep;18(3):323-337. Review.


Sex and diagnosis specific associations between DNA methylation of the oxytocin receptor gene with emotion processing and temporal-limbic and prefrontal brain volumes in psychotic disorders.

Rubin LH, Connelly JJ, Reilly JL, Carter CS, Drogos LL, Pournajafi-Nazarloo H, Ruocco AC, Keedy SK, Matthew I, Tandon N, Pearlson GD, Clementz BA, Tamminga CA, Gershon ES, Keshavan MS, Bishop JR, Sweeney JA.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Mar 1;1(2):141-151. Epub 2015 Nov 9.


Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis.

Huang E, Zai CC, Lisoway A, Maciukiewicz M, Felsky D, Tiwari AK, Bishop JR, Ikeda M, Molero P, Ortuno F, Porcelli S, Samochowiec J, Mierzejewski P, Gao S, Crespo-Facorro B, Pelayo-Terán JM, Kaur H, Kukreti R, Meltzer HY, Lieberman JA, Potkin SG, Müller DJ, Kennedy JL.

Int J Neuropsychopharmacol. 2016 Apr 29;19(5). pii: pyv132. doi: 10.1093/ijnp/pyv132. Print 2016 May. Review.


Atomoxetine pharmacogenetics: associations with pharmacokinetics, treatment response and tolerability.

Brown JT, Bishop JR.

Pharmacogenomics. 2015;16(13):1513-20. doi: 10.2217/PGS.15.93. Epub 2015 Aug 28. Review.


Escitalopram pharmacogenetics: CYP2C19 relationships with dosing and clinical outcomes in autism spectrum disorder.

Bishop JR, Najjar F, Rubin LH, Guter SJ, Owley T, Mosconi MW, Jacob S, Cook EH.

Pharmacogenet Genomics. 2015 Nov;25(11):548-54. doi: 10.1097/FPC.0000000000000173.


Pharmacogenetic Study of Serotonin Transporter and 5HT2A Genotypes in Autism.

Najjar F, Owley T, Mosconi MW, Jacob S, Hur K, Guter SJ, Sweeney JA, Gibbons RD, Cook EH, Bishop JR.

J Child Adolesc Psychopharmacol. 2015 Aug;25(6):467-74. doi: 10.1089/cap.2014.0158.


SNP genotyping using TaqMan technology: the CYP2D6*17 assay conundrum.

Gaedigk A, Freeman N, Hartshorne T, Riffel AK, Irwin D, Bishop JR, Stein MA, Newcorn JH, Jaime LK, Cherner M, Leeder JS.

Sci Rep. 2015 Mar 19;5:9257. doi: 10.1038/srep09257.

Supplemental Content

Loading ...
Support Center